Michael Burry’s portfolio: Scion Asset Management 13F holdings

Quarterly SEC 13F-HR filingsCIK 0001649339Latest: Q3 2025

Q4 2015 filing in brief

In its Q4 2015 13F, filed February 16, 2016, Scion Asset Management reported $80M across 14 US positions. The largest: NXRT (11.0%), AAPL (9.9%), THERAVANCE BIOPHARMA INC (8.9%), IBM (8.6%), FSLR (8.3%).

Methodology

Holdings come from the manager’s Form 13F-HR filings on SEC EDGAR, with amendments applied. Values and shares are reported at quarter-end; the filing date is when the report became public. These disclosures show reported long positions and listed options, not the manager’s entire portfolio or its trades since quarter-end.

Quarterly changes compare shares with the immediately preceding quarter on file. New and exited positions appear or disappear; added and trimmed positions change their share count by more than 1%. A share change can also reflect a stock split or other corporate action.

Opened and sold out is the value of new positions plus the prior value of exited positions, divided by the average of the two quarters’ reported portfolio values. It excludes changes to positions still held. Reported value growth includes price changes and is not a measure of investment performance. Largest-five and largest-ten weights exclude options.

Holdings

Filed Feb 16, 2016

14 positions at December 31, 2015. No preceding quarter on file for comparison.

RowTickerIssuerStatus
1NXRTNEXPOINT RESIDENTIAL TR INC$9M670.8K10.98%——
2AAPLAPPLE INC$8M75.0K9.88%——
3—THERAVANCE BIOPHARMA INC$7M436.6K8.95%——
4IBMINTERNATIONAL BUSINESS MACHS$7M50.0K8.61%——
5FSLRFIRST SOLAR INC$7M100.0K8.26%——
6—MENS WEARHOUSE INC$6M400.0K7.35%——
7—ACE LTD$6M50.0K7.31%——
8CYHCOMMUNITY HEALTH SYS INC NEW$5M200.0K6.64%——
9CCITIGROUP INC$5M100.0K6.47%——
10HCAHCA HOLDINGS INC$5M75.0K6.34%——
11BACBANK AMER CORP$5M300.0K6.32%——
12BNYBANK NEW YORK MELLON CORP$4M100.0K5.16%——
13PNCPNC FINL SVCS GROUP INC$4M40.0K4.77%——
14—CNX COAL RES LP$2M256.3K2.97%——
Every quarter on file (32)
2025Q1Q2Q3
2024Q1Q2Q3Q4
2023Q1Q2Q3Q4
2022Q1Q2Q3Q4
2021Q1Q2Q3Q4
2020Q1Q2Q3Q4
2019Q1Q2Q3Q4
2018Q4
2016Q1Q2Q3
2015Q4

From the manager’s Form 13F-HR filings on SEC EDGAR, amendments applied. Long US positions only; not a recommendation.